Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GGPS1 | O95749 | 2/20 | 0.35 |
| ▸ | ROCK1 | Q13464 | 3/20 | 0.33 |
| ▸ | PRKACA | P17612 | 2/20 | 0.33 |
| ▸ | GSK3A | P49840 | 2/20 | 0.33 |
| ▸ | GSK3B | P49841 | 2/20 | 0.33 |
| ▸ | PRKX | P51817 | 2/20 | 0.33 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.33 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.33 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.33 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.33 |
| ▸ | CDK2 | P24941 | 1/20 | 0.33 |
| ▸ | AKT2 | P31751 | 1/20 | 0.33 |
| ▸ | IRAK1 | P51617 | 1/20 | 0.33 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.33 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.33 |
| ▸ | PRKG2 | Q13237 | 1/20 | 0.33 |
| ▸ | PRKG1 | Q13976 | 1/20 | 0.33 |
| ▸ | PKN2 | Q16513 | 1/20 | 0.33 |
| ▸ | MINK1 | Q8N4C8 | 1/20 | 0.33 |
| ▸ | HIPK4 | Q8NE63 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7947624 | 0.90 | HDAC4 (0.33) | KMT2AKDM4EALDH1A1CHRNB2CHRNB4 | |
| SCHEMBL7947620 | 0.90 | HDAC4 (0.33) | KMT2AKDM4EALDH1A1CHRNB2CHRNB4 | |
| SCHEMBL30192558 | 0.85 | — | — | |
| SCHEMBL3861123 | 0.85 | MKNK1 (0.37) | — | |
| SCHEMBL3861120 | 0.85 | MKNK1 (0.37) | — | |
| SCHEMBL14714255 | 0.82 | KMT2A (0.52) | PRKCDKMT2AALOX5 | |
| SCHEMBL28116069 | 0.82 | KMT2A (0.52) | PRKCDKMT2AALOX5 | |
| SCHEMBL14699396 | 0.79 | CYP1A2 (0.37) | KDM4ENPC1RAB9A | |
| SCHEMBL14699398 | 0.79 | CYP1A2 (0.37) | KDM4ENPC1RAB9A | |
| SCHEMBL14714190 | 0.79 | CYP2D6 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230142546-A1 | RADIOPHARMACEUTICALS AND COMPOSITION FOR THROMBUS IMAGING | THE ASAN FOUNDATION (KR) | 2023-05-11 | — | — | US | disclosed |
| US-20230129721-A1 | STABILIZER FOR RADIOPHARMACEUTICALS AND RADIOPHARMACEUTICAL COMPOSITION COMPRISING THE SAME | THE ASAN FOUNDATION (KR) | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230142546-A1 | RADIOPHARMACEUTICALS AND COMPOSITION FOR THROMBUS IMAGING | SERPINC1, F3, F11 | GGPS1 1676/4885ROCK1 461/4885PRKACA 4340/4885 |
| US-20230129721-A1 | STABILIZER FOR RADIOPHARMACEUTICALS AND RADIOPHARMACEUTICAL COMPOSITION COMPRISING THE SAME | GC, ADORA2B, TBCB | GGPS1 225/4885ROCK1 3819/4885PRKACA 4738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.